Afri-Can Forum 2
A1 Introduction to the 2nd synchronicity forum of GHRI/CHVI-funded Canadian and African HIV prevention and vaccine teams
Volume 16 Supplement 2
Publication of this supplement has been supported by the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) through a Planning and Dissemination Grant. Another important supporting partner in the Afri-Can Forum 2 was the Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Coordinating Office (ACO).
Johannesburg, South Africa16-18 February 2015
A1 Introduction to the 2nd synchronicity forum of GHRI/CHVI-funded Canadian and African HIV prevention and vaccine teams
2022 Citation Impact
3.7 - 2-year Impact Factor
3.6 - 5-year Impact Factor
1.283 - SNIP (Source Normalized Impact per Paper)
1.055 - SJR (SCImago Journal Rank)
2023 Speed
28 days submission to first editorial decision for all manuscripts (Median)
148 days submission to accept (Median)
2023 Usage
6,949,317 downloads
28,444 Altmetric mentions
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication